| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |